Abstract
The guiding principles for populational COVID-19 vaccine selection: A normative analysis through comparison of the strategies in Hong Kong and Singapore.
Highlights
Preliminary study showed similar efficacy to neutralise mutant Data not available [16] viruses that emerged from the UK and South Africa [15]
Summary on efficacies: Comirnaty proves to be superior to CoronaVac in terms of efficacy overall, for severe disease, for elderly people and for people at risk with comorbidities or obesity, and possibly against mutant viruses from the UK and South Africa
This is a sign that the immune response is successfully induced and the majority of these events were mild or moderate in severity, lasting only one day [17]. These self-limiting short term systemic reactions pose no significant health threat to the recipients. With this in mind as well as the better efficacy-safety profiles of mRNA vaccines, population-wide provision of mRNA vaccines instead of traditional ones are in full conformity with the ethical principles of beneficence and non-maleficence
Summary
COVID-19 vaccination campaigns are under way in many parts of the world to protect individuals, reduce overall infection and restore normality. My article aims to normatively derive the guiding principles for populational vaccine selection using comparison of the strategies in Hong Kong and Singapore. I briefly describe the vaccination campaigns in both cities and normatively derive the guiding principles for vaccine selection by an inquisitive and comparative approach Both cities acknowledge that the vaccination campaigns aim at protecting individuals against infection, safeguarding public health and restoring normality. The analysis compares the vaccine selection strategies in Hong Kong and Singapore and inquisitively questions which strategy better serves social interest of reducing overall infection and restoring normality, which strategy better serves the individual medical interests of the vaccine recipients and whether the efficacy-safety profiles of different approved vaccines should be compared. The guiding principles for populational vaccine selection are delineated
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
